LifeTech Scientific Corporation (81X.F)

0.1820 +0.0160 (+9.64%) 收市：08:05AM CEST

LifeTech Scientific Corporation

LifeTech Scientific Building
No.22, Keji 12th Road South High-tech Industrial Park Nanshan District
Shenzhen 518063
China
86 75 5860 26250
https://www.lifetechmed.com

版塊: Healthcare
行業: Medical Devices
全職員工: 1,448

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Yuehui Xie	Chairman & CEO	1.08M	無	1969
Mr. Jianxiong Liu ACCA	CFO, Executive VP, Company Secretary & Executive Director	879.45k	無	1971

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。

描述

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders worldwide. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; Futhrough endovascular needle systems; delivery systems, such as Fustar steerable and SteerEase introducers; Zoetrack guidewire; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; HearTone implantable cardiac pacing system; and SeQure snare systems, as well as pacemakers. The company is also involved in the biomedical research and development; properties leasing business; and manufacturing and trading of medical devices, as well as offers technical, consulting, and technology services. The company was founded in 1999 and is headquartered in Shenzhen, China.

公司管治

截至 無 止，LifeTech Scientific Corporation 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。